Cosmo Bio Co (TSE:3386) 10-Year ROIIC %

: 11.97% (As of Dec. 2021)

View and export this data going back to 2005. Start your Free Trial

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Cosmo Bio Co's 10-Year ROIIC % for the quarter that ended in Dec. 2021 was 11.97%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Cosmo Bio Co's 10-Year ROIIC % or its related term are showing as below:

TSE:3386's 10-Year ROIIC % is ranked better than
64.44% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.24 vs TSE:3386: 11.97

Competitive Comparison

For the Diagnostics & Research subindustry, Cosmo Bio Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Cosmo Bio Co 10-Year ROIIC % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Cosmo Bio Co's 10-Year ROIIC % falls in comparison to its industry or sector. The grey bar indicates the 10-Year ROIIC %'s extreme value range as defined by GuruFocus.

Cosmo Bio Co 10-Year ROIIC % Calculation

Cosmo Bio Co's 10-Year ROIIC % for the quarter that ended in Dec. 2021 is calculated as:

10-Year ROIIC %	=	10-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	10-Year Incremental Invested Capital^**
	=	( 733.9853 (Dec. 2021) - 505.4072 (Dec. 2011) )	/	( 5606 (Dec. 2021) - 3696 (Dec. 2011) )
	=	228.5781	/	1910
	=	11.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

^**Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.

Cosmo Bio Co (TSE:3386) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Cosmo Bio Co 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Cosmo Bio Co's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Bio Co (TSE:3386) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cosmo Bio Co Ltd (TSE:3386) » Definitions » 10-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016

Website

http://www.cosmobio.co.jp

Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.

Cosmo Bio Co (TSE:3386) Headlines

No Headlines